Drug General Information |
Drug ID |
DXM9HG
|
Drug Name |
SID3711335
|
Synonyms |
CHEMBL1365170
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Formula |
C12H9ClO2S
|
Canonical SMILES |
Clc1ccc(SCC(=O)c2occc2)cc1
|
InChI |
InChI=1S/C12H9ClO2S/c13-9-3-5-10(6-4-9)16-8-11(14)12-2-1-7-15-12/h1-7H,8H2
|
InChIKey |
FGUSBXJCUKGJCC-UHFFFAOYSA-N
|
Target and Pathway |
Target(s) |
Estrogen receptor beta |
Target Info |
|
[1]
|
Induced myeloid leukemia cell differentiation protein Mcl-1 |
Target Info |
|
[1]
|
KEGG Pathway
|
Estrogen signaling pathway
|
Prolactin signaling pathwayhsa04151:PI3K-Akt signaling pathway
|
MicroRNAs in cancer
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Apoptosis signaling pathway
|
CCKR signaling map ST
|
Pathway Interaction Database
|
Plasma membrane estrogen receptor signaling
|
Validated nuclear estrogen receptor beta network
|
Validated nuclear estrogen receptor alpha networke2f_pathway:E2F transcription factor network
|
Direct p53 effectors
|
IL6-mediated signaling events
|
HIF-1-alpha transcription factor network
|
Reactome
|
Nuclear Receptor transcription pathway
|
WikiPathways
|
SIDS Susceptibility Pathways
|
Ovarian Infertility Genes
|
Integrated Pancreatic Cancer Pathway
|
Nuclear ReceptorsWP254:Apoptosis
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in leukocytes - TarBase
|
Apoptosis Modulation and Signaling
|
References |
REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |